Kaplan–Meier curves demonstrated that high GPATCH3 expression is associated with reduced overall survival in multiple cancer types, including lower-grade glioma (LGG), liver hepatocellular carcinoma (LIHC), and prostate adenocarcinoma (PRAD) (Figures 4B–D). Here, GPATCH3 is linked to prostate adenocarcinoma.